Population assessment of tobacco and health (PATH) study period of performance: 02/01/2024-01/31/2029
Active Definitive Contract Awarded Last action
- Contract number
- 75N95024C00003
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $85,470,330
Award facts
- Opportunity
-
- Request for Information: Population Assessment of Tobacco and Health (PATH) Study for the National Institute on Drug Abuse Pre-Solicitation · 75N95023R00001 · Posted Mar 5, 2021
- Contract value 11% obligated
-
- $85,470,330.00 Current, with exercised options
- $780,533,839.00 Potential, with all options
- Completion date 21% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $47,794,785 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $29,881,863 | |
| Change Order | $0 | |
| Exercise an Option | $576,252 | |
| Exercise an Option | $5,634,540 | |
| Add Subcontract Plan | $0 | |
| Original award | $1,582,890 |
Show all 12
About this award
The National Institute on Drug Abuse awarded a $780.5 million definitive contract to Westat, Inc. on February 1, 2024, for the Population Assessment of Tobacco and Health (PATH) Study, a longitudinal research effort spanning February 2024 through November 2030, with ultimate completion by November 2036.
Work is performed in Rockville, MD. The contract is cost-plus-fixed-fee, competed full-and-open with no set-aside.
The PATH Study is a signature population-level epidemiological research program requiring sustained data collection, statistical analysis, and program evaluation across multiple survey waves and cohorts. The pre-solicitation was posted March 5, 2021.
Service Contract Inventory data reflects actual government-invoiced activity: FY2024 invoiced $1.8 million across 6.8 FTEs and 14,194 contractor hours at a derived rate of $125.68/hr; FY2025 invoiced $14.8 million across 48.7 FTEs and 101,311 contractor hours at $145.92/hr. The labor footprint is rising year-over-year, with one subcontractor engaged in FY2025. Westat self-performs the majority of work as prime.
Quick answers
Who was awarded contract 75N95024C00003?
75N95024C00003 was awarded to Westat, Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 1, 2024.
How much is contract 75N95024C00003 worth?
The government has obligated $85,470,330 on 75N95024C00003. Its potential value, with all options, is $780,533,839.
Was contract 75N95024C00003 competed?
The extent of competition for 75N95024C00003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award